SMITHKLINE BEECHAM’s AUGMENTIN AUGMENTS 1991 REVENUES BY $942 MIL., OR 20% OF PHARMACEUTICAL SALES; SEROXAT HOLDS 11% SHARE OF U.K. ANTIDEPRESSANT MARKET